4CPS-122 Efficacy of different chemotherapy regimens associated with trastuzumab in her2-positive advanced gastric cancer: data from the national register agamenon

A Martinez Torròn; F Alvarez-Manceñido; I Zapico Garcia; A Rodriguez Palomo; M Alaguero Calero; A Carmona-Bayonas; P Reguera; G Aguado; A Sánchez; A Lozano-Blázquez

doi:10.1136/ejhpharm-2018-eahpconf.213

Article info

Section 4: Clinical pharmacy services

4CPS-122 Efficacy of different chemotherapy regimens associated with trastuzumab in her2-positive advanced gastric cancer: data from the national register agamenon

Authors

A Martinez Torròn 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles
F Alvarez-Manceñido 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles
I Zapico Garcia 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles
A Rodriguez Palomo 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles
M Alaguero Calero 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles
A Carmona-Bayonas 2Hospital Universitario Morales Meseguer, Medical Oncologist, Murcia, Spain PubMed articles Google scholar articles
P Reguera 3Hospital Universitario Ramón y Cajal, Medical Oncologist, Madrid, Spain PubMed articles Google scholar articles
G Aguado 4Hospital Universitario Gregorio Marañon, Medical Oncologist, Madrid, Spain PubMed articles Google scholar articles
A Sánchez 5Hospital Universitario Doce de Octubre, Medical Oncologist, Madrid, Spain PubMed articles Google scholar articles
A Lozano-Blázquez 1Hospital Universitario Central de Asturias, Hospital Pharmacist, Oviedo, Spain PubMed articles Google scholar articles

Citation

Torròn AM, Alvarez-Manceñido F, Garcia IZ, et al

4CPS-122 Efficacy of different chemotherapy regimens associated with trastuzumab in her2-positive advanced gastric cancer: data from the national register agamenon

European Journal of Hospital Pharmacy 2018;25:A98-A99.

Publication history

First published March 2, 2018.

Online issue publication

April 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password